Ferreri, A.J., Reni, M., Foppoli, M., Martelli, M., Pangalis, G.A., Frezzato, M., et al. (2009) High-Dose Cytarabine plus High-Dose Methotrexate versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial. The Lancet, 374, 1512-1520.
http://dx.doi.org/10.1016/S0140-6736(09)61416-1

has been cited by the following article:

• TITLE: Primary Cerebral Lymphoma: About 22 Cases with Literature Review

  AUTHORS: Adama Diakité, Aphou Salle Koné, Idrissa Mama Diarra, Koniba Diabaté, Tayeb Kebdani, Noureddine Benjaafar

  KEYWORDS: Primitive Cerebral Lymphoma, Chemotherapy, Radiotherapy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.7 No.7, July 8, 2016

  ABSTRACT: Primitive cerebral lymphoma (PCL) is a rare entity often poorly known. They are defined as extra nodal tumor interesting the CNS, brain and eye, and this in the absence of systemic lymphoma disease and brain metastases. The favoring factor is established immunosuppression which is explained by an increase in the incidence related to HIV. The basis of treatment is chemotherapy with consolidation radiotherapy. We report the experience of the National Institute of Oncology in Rabat in management of this disease.